Senti Biosciences Holdings, Inc.
SNTI
$0.30
-$0.02-5.32%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -12.35% | -3.65% | 9.40% | 5.30% | -1.13% |
| Gross Profit | 12.50% | 3.76% | -9.33% | -5.30% | 0.19% |
| SG&A Expenses | 8.20% | 21.86% | 12.66% | -9.98% | -25.16% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -5.27% | 4.45% | 10.47% | -0.66% | -10.97% |
| Operating Income | 5.37% | -4.37% | -10.43% | 0.66% | 10.48% |
| Income Before Tax | 15.02% | 5.92% | -16.38% | 32.86% | 25.82% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 15.02% | 5.92% | -16.38% | 32.86% | 25.82% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 15.02% | 5.92% | -16.38% | 32.89% | -2.40% |
| EBIT | 5.37% | -4.37% | -10.43% | 0.66% | 10.48% |
| EBITDA | 4.64% | -5.53% | -11.70% | 0.32% | 10.26% |
| EPS Basic | 80.28% | 82.28% | 73.56% | 78.60% | 29.21% |
| Normalized Basic EPS | 60.28% | 69.69% | 60.95% | 76.21% | 61.74% |
| EPS Diluted | 80.28% | 82.28% | 73.56% | 78.60% | 29.21% |
| Normalized Diluted EPS | 60.28% | 69.69% | 60.95% | 76.21% | 61.74% |
| Average Basic Shares Outstanding | 155.28% | 364.51% | 388.02% | 268.33% | 151.07% |
| Average Diluted Shares Outstanding | 155.28% | 364.51% | 388.02% | 268.33% | 151.07% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |